We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-22.13%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$222M
AUM Growth
-$73.3M
Cap. Flow
+$3.18M
Cap. Flow %
1.43%
Top 10 Hldgs %
32.84%
Holding
151
New
20
Increased
39
Reduced
28
Closed
37

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$7.06M
2
BBY icon
Best Buy
BBY
+$4.32M
3
WFC icon
Wells Fargo
WFC
+$4.1M
4
AAPL icon
Apple
AAPL
+$3.13M
5
AIG icon
American International
AIG
+$2.92M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.99M
2
GILD icon
Gilead Sciences
GILD
+$3.41M
3
LUV icon
Southwest Airlines
LUV
+$2.92M
4
ORCL icon
Oracle
ORCL
+$2.8M
5
NKE icon
Nike
NKE
+$2.76M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Healthcare 15.43%
3 Financials 14.82%
4 Communication Services 10.81%
5 Consumer Discretionary 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABMD
151
DELISTED
Abiomed Inc
ABMD
-6,860
Closed -$1.17M

Similar funds

Stoneridge Investment Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Stoneridge Investment Partners held 151 positions worth $222M, down 25% from $296M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stoneridge Investment Partners's Q1 2020 filing shows 20 new, 39 increased, 28 reduced and 37 closed positions. Its largest new stake was Walgreens Boots Alliance: 139,156 shares worth $6.37M. The largest sale was Johnson & Johnson, an estimated $3.99M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Stoneridge Investment Partners's largest Q1 2020 buy was Walgreens Boots Alliance: 139,156 shares worth $6.37M.
  • Stoneridge Investment Partners added most to Wells Fargo in Q1 2020, an estimated $4.1M increase.
  • Stoneridge Investment Partners's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $3.99M.
  • Stoneridge Investment Partners fully exited Gilead Sciences in Q1 2020, selling an estimated $3.41M.
  • Stoneridge Investment Partners's ten largest holdings make up 33% of its $222M portfolio in Q1 2020.
  • Stoneridge Investment Partners opened 20 new positions and closed 37 in Q1 2020.
  • Stoneridge Investment Partners's portfolio value fell 25% quarter-over-quarter to $222M.

Based on Stoneridge Investment Partners's 13F filing for Q1 2020, filed 5 May 2020.